2024-11-19 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**1. Performance Comparison and Divergence:**

UnitedHealth Group (UNH) significantly outperformed the S&P 500 (VOO) over the given period.  UNH's cumulative return of 201.38% is 76.6 percentage points higher than VOO's 124.78%.  The relative divergence of 48.37% indicates that UNH's performance is in the upper range of its historical performance relative to the S&P 500.  This suggests strong historical outperformance.

**Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company providing health insurance, health care delivery, and information and technology services.

**Alpha and Beta Analysis:** The provided data shows consistently high CAGR (Compound Annual Growth Rate) for UNH across various periods, ranging from 57% to 129.6%.  Alpha values mostly hover around 0.9-1.1, suggesting that UNH generally outperforms the market, although this decreased to 0.5 in the most recent period. Beta values fluctuate slightly, but generally remain around 0.9-1.1, indicating a relatively high correlation with the overall market. Market capitalization has steadily increased over time.  The Maximum Drawdown (MDD) varies considerably across periods.  Note that these figures represent past performance and are not indicative of future results.

**2. Recent Price Movement:**

* **Closing Price:** $589.65 (Last Market: $589.71)
* **5-Day Moving Average:** $599.11 (Slightly above the closing price, suggesting a recent slight downturn)
* **20-Day Moving Average:** $582.29 (Below the closing price, suggesting a potential upward trend)
* **60-Day Moving Average:** $584.0 (Below the closing price, supporting the potential upward trend)

The price is currently slightly above the 20-day and 60-day moving averages, which is generally a positive sign. However, it is below the 5-day moving average which could signal a minor short-term correction.

**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 61.63 – This indicates neither overbought nor oversold conditions; the stock is in a neutral zone.
* **PPO (Price Oscillator):** 0.22 – A positive value suggests a bullish momentum.
* **20-Day Relative Divergence:** 4.39 (+) – This positive change shows a recent short-term upward trend.
* **Expected Return (Long-Term):** 36.78% –  This suggests a significant potential for outperformance relative to the S&P 500 over a long-term (2+ years) investment horizon.  The last price of 589.71 does not show any significant issues like a rapid increase or decrease.

**4. Recent Financial Performance and Outlook:**

The provided financial data shows fluctuating EPS and revenue, although overall revenue shows a mostly upward trend. The negative EPS in 2024-05-09 is noteworthy and needs further investigation to understand the underlying causes.  It's important to compare these results to analyst expectations and consider the seasonality of the healthcare industry.  The most recent earnings (2024-11-04) show high EPS and Revenue figures, exceeding the previous quarter.  More data and analysis would be needed to provide a robust outlook.  Specific details regarding the 2024-11-04 earnings (whether it met, exceeded, or fell short of analyst expectations) would greatly improve the quality of this analysis.


**6. Financial Information:**

* **Revenue and Profitability:**  Revenue is relatively consistent, fluctuating slightly. Profit margins show some minor fluctuation but remain strong, generally in the 21-24% range.
* **Capital and Profitability:** Equity generally shows an upward trend. ROE (Return on Equity) fluctuates, showing periods of both positive and negative returns, suggesting some volatility in profitability.

**7. News and Recent Issues:**

* **Missing Data:**  To provide comprehensive analysis on news, recent issues, market outlook, analyst opinions, and performance highlights, information from sources like Shacknews, FINBOLD, and other financial news outlets related to UNH within the last two days is crucial.  This information was not provided and would be essential to a thorough review.

**8. Summary:**

UNH has historically demonstrated strong outperformance compared to the S&P 500.  Technical indicators suggest a neutral to slightly bullish sentiment. The company displays robust revenue, although profitability shows some variability.  Long-term investment potential seems high based on the provided expected return.  However, more information is crucial, including recent news, earnings calls, and analyst reports, to accurately gauge current market sentiment and risk assessment.  The inconsistent ROE and the negative EPS in Q2 2024 warrant further investigation.

**9. Disclaimer:** This report is for informational purposes only and should not be considered investment advice. Conduct thorough due diligence before making any investment decisions.  The accuracy of this report depends entirely on the accuracy and completeness of the data provided.  Missing data regarding recent news, analyst opinions, and a detailed breakdown of the most recent earnings report severely limits the scope of this analysis.
